The global companion animal vaccines market is on track for significant growth, with Future Market Insights, Inc. researchers projecting a CAGR of 6.8% from 2023 to 2033. The market, valued at an estimated US$ 3.4 billion in 2023, is set to surpass US$ 6.7 billion by 2033, reflecting the increasing demand for vaccines in the companion animal healthcare sector.
This growth is driven by the rising awareness among pet owners about the importance of preventative healthcare for their animals, as well as advancements in vaccine technology that improve efficacy and ease of administration. With a growing global pet population and increasing veterinary care spending, the companion animal vaccines market is poised to expand significantly over the next decade.
Some factors expected to surge the market growth are:
- Humanization of pets.
- Growing awareness regarding pet insurance.
- Increase in the number of cases pertaining to animal diseases.
Routine vaccine programs for companion animals have eliminated some chronic scourges in developed countries. The improved focus on vaccination campaigns and higher awareness for pet care are fueling the demand for companion animal vaccines. The veterinary healthcare industry is witnessing increased demand for protozoan parasitic vaccines from countries in tropical and subtropical regions.
The development of resistance to various chemotherapeutic agents is contributing to increased demand for vaccines over anti-parasitic drugs. In this regard, scientists have noted that the production of third-generation DNA vaccines against protozoan parasites could prove essentially helpful. These vaccines are safe as they do not contain any pathogens. Moreover, these are more stable compared to live attenuated and killed viruses in the vaccine and cost-effective.
Another reason for the surge in the market includes increased awareness about zoonotic diseases and government initiatives to curb anti-microbial resistance among pets. The industry is also driven by rising awareness regarding animal diseases and technological advancements in the biotechnology market. For example, during the COVID-19 pandemic, there were vaccines that were launched for animals, like Ancovax and Carnivac-Cov. The vaccine has been developed by Rosselkhoznadzor, which is based out in Russia. Additionally, the government of India launched the CAN-CoV-2 ELISA kit, which detects COVID in canines.
Key Market Insights:
- Market Valuation: Estimated at US$ 3.4 billion in 2023, expected to reach US$ 6.7 billion by 2033.
- CAGR: The market is projected to grow at a CAGR of 6.8% from 2023 to 2033.
- Growth Drivers: Rising pet ownership, increased awareness of animal health, the expansion of veterinary care services, and the growing importance of vaccines in preventing infectious diseases in companion animals.
- Market Trends: The development of innovative vaccines, particularly for common and emerging diseases in pets, and the increasing availability of vaccines for various species, including dogs, cats, and exotic pets.
As pet owners increasingly recognize the value of proactive care, the demand for effective and safe vaccines continues to drive the growth of the companion animal vaccines market, ensuring a healthier future for pets worldwide.
Companion Animal Vaccines Market Segmentation
By Product Type:
- Attenuated Live Vaccines
- Conjugate Vaccines
- Inactivated Vaccines
- Subunit Vaccines
- Toxoid Vaccines
- DNA Vaccines
- Recombinant Vaccines
By Distribution Channel:
- Veterinary Clinics
- Veterinary Hospitals
- Veterinary Research Institutes
- Retail Pharmacies
By Species Types:
- Canine
- Avian
- Feline
By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- The Middle East and Africa (MEA)
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
